Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The course of symptoms of anxiety and depression from time of diagnosis up to 2 years follow-up in head and neck cancer patients treated with primary (chemo)radiation.
van Beek FE, Jansen F, Mak L, Lissenberg-Witte BI, Buter J, Vergeer MR, Voortman J, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. van Beek FE, et al. Among authors: voortman j. Oral Oncol. 2020 Mar;102:104576. doi: 10.1016/j.oraloncology.2020.104576. Epub 2020 Feb 3. Oral Oncol. 2020. PMID: 32028135 Free article.
Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
Hanemaaijer SH, Kok IC, Fehrmann RSN, van der Vegt B, Gietema JA, Plaat BEC, van Vugt MATM, Vergeer MR, Leemans CR, Langendijk JA, Voortman J, Buter J, Oosting SF. Hanemaaijer SH, et al. Among authors: voortman j. Front Oncol. 2020 Jun 5;10:761. doi: 10.3389/fonc.2020.00761. eCollection 2020. Front Oncol. 2020. PMID: 32582534 Free PMC article.
Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer.
Poel D, Rustenburg F, Sie D, van Essen HF, Eijk PP, Bloemena E, Elhorst Benites T, van den Berg MC, Vergeer MR, Leemans RC, Buffart TE, Ylstra B, Brakenhoff RH, Verheul HM, Voortman J. Poel D, et al. Among authors: voortman j. Oral Oncol. 2020 Jun 22;109:104851. doi: 10.1016/j.oraloncology.2020.104851. Online ahead of print. Oral Oncol. 2020. PMID: 32585557
66 results